Scrip Roundtable Debate
Adopting Orphans - A Call to Arms for Collaboration Part 4: Regulatory pathways: fit for purpose?
Is there room for improvement in existing legislation concerning orphan diseases? Is global harmonisation of the regulatory requirements for orphan drugs a desirable goal? And who should take the lead?